KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 93 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,535 | -69.2% | 3,690 | -71.2% | 0.00% | – |
| Q2 2023 | $115,218 | +23.0% | 12,802 | +7.4% | 0.00% | – |
| Q1 2023 | $93,668 | +126.8% | 11,917 | +95.1% | 0.00% | – |
| Q4 2022 | $41,297 | -100.0% | 6,109 | -15.7% | 0.00% | – |
| Q3 2022 | $105,096,000 | +79.3% | 7,243 | +21.6% | 0.00% | – |
| Q2 2022 | $58,627,000 | +124.8% | 5,958 | +236.8% | 0.00% | – |
| Q1 2022 | $26,075,000 | -58.7% | 1,769 | -62.9% | 0.00% | – |
| Q4 2021 | $63,134,000 | +0.5% | 4,772 | +32.6% | 0.00% | – |
| Q3 2021 | $62,803,000 | +241.3% | 3,599 | +368.6% | 0.00% | – |
| Q2 2021 | $18,401,000 | -91.4% | 768 | -90.8% | 0.00% | – |
| Q1 2021 | $215,128,000 | +283.1% | 8,374 | +183.2% | 0.00% | – |
| Q4 2020 | $56,153,000 | +26.1% | 2,957 | -16.4% | 0.00% | – |
| Q3 2020 | $44,543,000 | +220.7% | 3,538 | +208.2% | 0.00% | – |
| Q2 2020 | $13,891,000 | -60.6% | 1,148 | -75.1% | 0.00% | – |
| Q1 2020 | $35,221,000 | +9.8% | 4,604 | +155.6% | 0.00% | – |
| Q4 2019 | $32,076,000 | +87.6% | 1,801 | +22.2% | 0.00% | – |
| Q3 2019 | $17,098,000 | +1035.3% | 1,474 | +2067.6% | 0.00% | – |
| Q2 2019 | $1,506,000 | – | 68 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
| COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
| Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
| Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
| Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
| Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
| APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
| Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |